| Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre … CC Boehme, MP Nicol, P Nabeta, JS Michael, E Gotuzzo, R Tahirli, ... The lancet 377 (9776), 1495-1505, 2011 | 1450 | 2011 |
| Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 patients SD Ahuja, D Ashkin, M Avendano, R Banerjee, M Bauer, JN Bayona, ... Public Library of Science 9 (8), e1001300, 2012 | 757 | 2012 |
| Evolutionary history and global spread of the Mycobacterium tuberculosis Beijing lineage M Merker, C Blin, S Mona, N Duforet-Frebourg, S Lecher, E Willery, ... Nature genetics 47 (3), 242-249, 2015 | 615 | 2015 |
| Regional sympathetic nervous activity and oxygen consumption in obese normotensive human subjects M Vaz, G Jennings, A Turner, H Cox, G Lambert, M Esler Circulation 96 (10), 3423-3429, 1997 | 550 | 1997 |
| Resistance to fluoroquinolones and second-line injectable drugs: impact on multidrug-resistant TB outcomes D Falzon, N Gandhi, GB Migliori, G Sotgiu, HS Cox, TH Holtz, ... European Respiratory Journal 42 (1), 156-168, 2013 | 513 | 2013 |
| Building a tuberculosis-free world: The Lancet Commission on tuberculosis MJA Reid, N Arinaminpathy, A Bloom, BR Bloom, C Boehme, R Chaisson, ... The Lancet 393 (10178), 1331-1384, 2019 | 394 | 2019 |
| Drug-resistant tuberculosis: time for visionary political leadership I Abubakar, M Zignol, D Falzon, M Raviglione, L Ditiu, S Masham, I Adetifa, ... The Lancet infectious diseases 13 (6), 529-539, 2013 | 378 | 2013 |
| Tuberculosis diagnostics and biomarkers: needs, challenges, recent advances, and opportunities R McNerney, M Maeurer, I Abubakar, B Marais, TD Mchugh, N Ford, ... Journal of Infectious Diseases 205 (suppl_2), S147-S158, 2012 | 282 | 2012 |
| Xpert MTB/RIF versus sputum microscopy as the initial diagnostic test for tuberculosis: a cluster-randomised trial embedded in South African roll-out of Xpert MTB/RIF GJ Churchyard, WS Stevens, LD Mametja, KM McCarthy, V Chihota, ... The Lancet Global Health 3 (8), e450-e457, 2015 | 262 | 2015 |
| Effects of aging on the responsiveness of the human cardiac sympathetic nerves to stressors MD Esler, JM Thompson, DM Kaye, AG Turner, GL Jennings, HS Cox, ... Circulation 91 (2), 351-358, 1995 | 236 | 1995 |
| Linezolid for the treatment of complicated drug-resistant tuberculosis: a systematic review and meta-analysis H Cox, N Ford The International journal of tuberculosis and lung disease 16 (4), 447-454, 2012 | 234 | 2012 |
| Long term efficacy of DOTS regimens for tuberculosis: systematic review HS Cox, M Morrow, PW Deutschmann Bmj 336 (7642), 484-487, 2008 | 221 | 2008 |
| Tuberculosis recurrence and mortality after successful treatment: impact of drug resistance H Cox, Y Kebede, S Allamuratova, G Ismailov, Z Davletmuratova, ... PLoS medicine 3 (10), e384, 2006 | 221 | 2006 |
| Drug-resistant tuberculosis—current dilemmas, unanswered questions, challenges, and priority needs A Zumla, I Abubakar, M Raviglione, M Hoelscher, L Ditiu, TD Mchugh, ... Journal of Infectious Diseases 205 (suppl_2), S228-S240, 2012 | 220 | 2012 |
| The 2021 WHO catalogue of Mycobacterium tuberculosis complex mutations associated with drug resistance: a genotypic analysis TM Walker, P Miotto, CU Köser, PW Fowler, J Knaggs, Z Iqbal, M Hunt, ... The Lancet Microbe 3 (4), e265-e273, 2022 | 193 | 2022 |
| Genomic Diversity among Drug Sensitive and Multidrug Resistant Isolates of Mycobacterium tuberculosis with Identical DNA Fingerprints S Niemann, CU Köser, S Gagneux, C Plinke, S Homolka, H Bignell, ... PloS one 4 (10), e7407, 2009 | 188 | 2009 |
| Drug-resistant tuberculosis: challenges and opportunities for diagnosis and treatment A Koch, H Cox, V Mizrahi Current Opinion in pharmacology 42, 7-15, 2018 | 186 | 2018 |
| Impact of Xpert MTB/RIF for TB diagnosis in a primary care clinic with high TB and HIV prevalence in South Africa: a pragmatic randomised trial HS Cox, S Mbhele, N Mohess, A Whitelaw, O Muller, W Zemanay, F Little, ... PLoS medicine 11 (11), e1001760, 2014 | 186 | 2014 |
| Outcomes of clofazimine for the treatment of drug-resistant tuberculosis: a systematic review and meta-analysis T Dey, G Brigden, H Cox, Z Shubber, G Cooke, N Ford Journal of antimicrobial chemotherapy 68 (2), 284-293, 2013 | 179 | 2013 |
| The Beijing genotype and drug resistant tuberculosis in the Aral Sea region of Central Asia HS Cox, T Kubica, D Doshetov, Y Kebede, S Rüsch-Gerdess, S Niemann Respiratory research 6, 1-9, 2005 | 169 | 2005 |